Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?

Journal of Association of Physicians of India

Volumn 52, Issue OCT, 2004, Pages 785-787

  Anand, A C ^a   Nagpal, A K ^a   Seth, A K ^a   Dhot, P S ^a  

^a ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOLOGY; INDIA; LIVER DISEASE; MALE;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HUMANS; IMMUNOGLOBULIN G; INDIA; LIVER DISEASES; MALE;

EID: 19444371892     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunisation Practices. Morb Mortal Wkly Rep MMWR 1999;48:1-37.
2. Vento S Garofano T, Renzini C, Cainelli F. Casali F, Ghironzi G, et al. Fulminant hepatitis associated with the hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
3. Yao G. Clinical spectrum and the natural history of viral hepatitis in a 1998 Shanghai epidemic. In: Holinger FB, Lemon SM, Margolis H (eds). Viral Hepatitis and Liver Disease. Baltimore: WilliamsandWilkins, 1991:76-8.
4. KeeffeEB, Iwarson S, McMahonBJ, Lindsay KL, Koff RS, Manns M, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998;27:881-6.
5. Acharya SK, Batra Y, Saraya A, Hazari S, Dixit R, Kaur K, et al. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India. Nat Med J India 2002;15:267-8.
6. Dal-Re R, Garcia-Corberia P, Garcia-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. J Med Viral 2000;60:363-6.
7. Gdalevich M, Grotto I, Mandel Y, Mimouni D, Shemer J, Ashkenazi I. Hepatitis A antibody prevalence among young adults in Israel- the decline continues. Epidemiol Infect 1998;121:477-9.
8. Sohn YM, Rho HO, Park MS, Park JH, Choi BY, Ki M, et al. The changing epidemiology of hepatitis A in children and the consideration of active immunisation in Korea. Yonsei Med J 2000; 41: 34-9.
9. Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000;18(supplI):S61-S64.
10. TanakaJ. Hepatitis A- shifting epidemiology in Latin America. Vaccine 2000;18(suppl1):S57-S60.
11. Mittal SK, Rastogi A, Rastogi A, Kumar N, Talukdar B, Kar P. Seroprevalence of hepatitis A in children-implications for hepatitis A vaccine. Trop Gasteroenterol 1998;19:120-2.
12. Aggarwal R, Naik S, Yachha SK, Naik SR. Seroprevalence of antibodies to hepatitis A virus among children in northern India. Indian Pediatr 1999;36:1248-50.
13. Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India 1982 and 1992. J Infect Dis 1995;171:447-50.
14. Das K, Kar P, Gupta RK. Are chronic liver disease patients at greater risk of hepatitis A superinfection? J Gastroenterol Hepatol 2001;16 (suppl ):A53.
15. Batra Y, Bhatkal B, Kaur K, Saraya A, Panda SK, Acharya SK.Vaccination against hepatitis A virus may not be required for school children in northern India: Results of a seroepidemiological survey. Bull World Health Organ 2002;80:728-31.